VDAC1 and acute kidney injury: Collectively, these results identify BBR684 as a potent ferroptosis inhibitor with therapeutic potential for AKI and other ferroptosis-related diseases.<h4>Conclusions</h4>BBR684 inhibits VDAC oligomerization to suppress ferroptosis in acute kidney injury.